BCL-2, in combination with MVP and IGF-1R expression, improves prediction of clinical outcome in complete response cervical carcinoma patients treated by radiochemotherapy.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Luis A Henríquez-Hernandez |
| Publication date | June 25, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |